US Broker Ratings

Exelixis, Inc. (EXEL) Stock Analysis: Navigating Growth in the Biotech Sector Amid a Potential 7.69% Downside

Exelixis, Inc. (NASDAQ: EXEL), a prominent player in the biotechnology sector, is renowned for its pioneering work in oncology treatment. With a focus on discovering, developing, and commercializing new cancer..

Bio-Techne Corp (TECH) Stock Analysis: Evaluating the Growth Potential Amidst a Competitive Biotech Landscape

Bio-Techne Corp (NASDAQ: TECH) stands as a significant player in the healthcare sector, particularly within the biotechnology industry. With a market capitalization of approximately $11.39 billion, Bio-Techne is a notable..

Roivant Sciences Ltd. (ROIV) Stock Analysis: A Biotech Powerhouse with 34.31% Potential Upside

Roivant Sciences Ltd. (NASDAQ: ROIV), a prominent player in the biotechnology sector, presents a compelling case for investors seeking opportunities in the healthcare industry. With a market capitalization of $25.86..

Takeda Pharmaceutical Company L (TAK) Investor Outlook: Analyzing 17.27% Potential Upside

Takeda Pharmaceutical Company Limited (NYSE: TAK), a stalwart in the healthcare sector with a market cap of $60.23 billion, is drawing attention with its impressive 17.27% potential upside. As a..

Boston Scientific Corporation (BSX) Stock Analysis: Uncovering a 38.89% Potential Upside in the Medical Device Sector

Boston Scientific Corporation (NYSE: BSX), a prominent player in the healthcare sector, particularly in the medical devices industry, is capturing the attention of investors with its impressive growth prospects and..

Summit Therapeutics Inc. (SMMT) Stock Analysis: Potential Upside of Over 83% Sparks Investor Interest

Summit Therapeutics Inc. (NASDAQ: SMMT), a biopharmaceutical company focused on developing innovative therapies for cancer treatment, stands out with a potential upside of 83.54%. This promising figure, driven by the..

Penumbra, Inc. (PEN) Stock Analysis: Exploring a 13.47% Potential Upside in the Thriving Medical Devices Sector

Penumbra, Inc. (PEN), a prominent player in the medical devices industry, is capturing the attention of investors due to its significant growth potential and strategic positioning in the healthcare sector...

Corcept Therapeutics (CORT) Stock Analysis: Exploring a 21% Potential Upside for Investors

Corcept Therapeutics Incorporated (CORT) stands as a prominent player in the healthcare sector, particularly within the biotechnology industry. The company, headquartered in Redwood City, California, is dedicated to the discovery..

ICON plc (ICLR) Stock Analysis: Unpacking the Potential for a 7.5% Upside in the Healthcare Sector

ICON plc (NASDAQ: ICLR), a leader in the clinical research space, stands as a pivotal player within the healthcare sector, with a robust market capitalization of $13.3 billion. Headquartered in..

STERIS plc (STE) Stock Analysis: Strong Buy Ratings and a Promising 25.94% Upside for Investors

For investors eyeing the healthcare sector, STERIS plc (NYSE: STE) offers a compelling investment opportunity with its robust market position and a noteworthy potential upside. The company, a leader in..

United Therapeutics Corporation (UTHR) Stock Analysis: Exploring a Potential 34% Upside in the Healthcare Sector

Investors seeking opportunities in the healthcare sector may find United Therapeutics Corporation (NASDAQ: UTHR) an intriguing prospect, particularly given its potential upside of 34.17% based on the average target price..

Labcorp Holdings Inc. (LH) Stock Analysis: A Look at Growth Potential and Analyst Ratings

Labcorp Holdings Inc. (NYSE: LH) stands as a formidable player in the healthcare sector, specifically within the diagnostics and research industry. With a market capitalization of $25.11 billion, Labcorp has..

Edwards Lifesciences Corporatio (EW)

⚠️ No article content returned.

..

CVS Health Corporation (CVS): Investor Outlook Highlights a Promising 30% Upside Potential

CVS Health Corporation (NYSE: CVS) stands as a formidable player in the healthcare sector, offering a comprehensive suite of health solutions across the United States. With a market capitalization of..

HCA Healthcare, Inc. (HCA) Stock Analysis: A Strong Buy with Solid Growth Potential

HCA Healthcare, Inc. (NYSE: HCA) continues to capture the attention of investors with its robust performance metrics and a strategic position in the U.S. healthcare sector. As one of the..

Centene Corporation (CNC) Stock Analysis: Unpacking a 16% Potential Upside for Healthcare Investors

Centene Corporation (NYSE: CNC), a leader in the healthcare plans industry, presents an intriguing opportunity for investors seeking exposure to the healthcare sector. With its headquarters in Saint Louis, Missouri,..

Solventum Corporation (SOLV) Investor Outlook: Navigating Potential Upsides in the Healthcare Sector

Solventum Corporation (SOLV), a key player in the healthcare sector, presents a compelling opportunity for investors with its diverse portfolio and strategic market positioning. Headquartered in Eagan, Minnesota, this medical..

Koninklijke Philips N.V. (PHG) Stock Analysis: With a 29% Upside Potential, Is It Time to Invest in This Healthcare Giant?

Koninklijke Philips N.V. (NYSE: PHG), a stalwart in the healthcare sector, presents a compelling case for investors looking to tap into the medical devices industry. With a market capitalization of..

Avantor, Inc. (AVTR) Stock Analysis: Navigating a Challenging Landscape with Strategic Resilience

Avantor, Inc. (AVTR), a prominent player in the healthcare sector specializing in medical instruments and supplies, has been attracting attention from investors as it navigates the complexities of the global..

Insmed Incorporated (INSM) Stock Analysis: Unveiling a 68.92% Potential Upside in the Biotechnology Sector

Investors with an eye on the biotechnology sector may find Insmed Incorporated (NASDAQ: INSM) an intriguing prospect. With a robust market cap of $25.73 billion, Insmed is making waves in..

Search

Funds

US Broker Ratings

Search

Funds

US Broker Ratings

FTSE 100

Funds